ANAB logo

AnaptysBio (ANAB) EBITDA

Annual EBITDA

-$92.74 M
+$50.42 M+35.22%

December 31, 2024


Summary


Performance

ANAB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANABprofitabilitymetrics:

Quarterly EBITDA

-$3.79 M
+$13.06 M+77.53%

December 31, 2024


Summary


Performance

ANAB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANABprofitabilitymetrics:

TTM EBITDA

-$92.74 M
+$32.87 M+26.17%

December 31, 2024


Summary


Performance

ANAB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherANABprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

ANAB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+35.2%+77.5%+26.2%
3 y3 years-70.9%+87.7%-70.9%
5 y5 years+2.4%+80.1%+2.4%

ANAB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.9%+35.2%at high+90.4%-70.9%+35.2%
5 y5-year-406.4%+35.2%-110.0%+90.4%-745.7%+35.2%
alltimeall time-1911.0%+35.2%-110.0%+90.4%-745.7%+35.2%

AnaptysBio EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$92.74 M(-35.2%)
-$3.79 M(-77.5%)
-$92.74 M(-26.2%)
Sep 2024
-
-$16.84 M(-52.0%)
-$125.61 M(-10.9%)
Jun 2024
-
-$35.10 M(-5.2%)
-$141.06 M(+0.1%)
Mar 2024
-
-$37.01 M(+1.0%)
-$140.85 M(-1.6%)
Dec 2023
-$143.16 M(+36.0%)
-$36.65 M(+13.5%)
-$143.16 M(+11.8%)
Sep 2023
-
-$32.28 M(-7.5%)
-$128.04 M(+4.5%)
Jun 2023
-
-$34.90 M(-11.3%)
-$122.54 M(+7.7%)
Mar 2023
-
-$39.33 M(+82.6%)
-$113.75 M(+8.1%)
Dec 2022
-$105.26 M(+94.0%)
-$21.53 M(-19.6%)
-$105.26 M(-8.0%)
Sep 2022
-
-$26.78 M(+2.6%)
-$114.43 M(+22.2%)
Jun 2022
-
-$26.11 M(-15.3%)
-$93.64 M(+39.4%)
Mar 2022
-
-$30.83 M(+0.4%)
-$67.17 M(+23.8%)
Dec 2021
-$54.26 M(+196.3%)
-$30.70 M(+412.0%)
-$54.26 M(-477.7%)
Sep 2021
-
-$6.00 M(-1784.6%)
$14.36 M(-494.5%)
Jun 2021
-
$356.00 K(-102.0%)
-$3.64 M(-86.1%)
Mar 2021
-
-$17.91 M(-147.2%)
-$26.11 M(+42.6%)
Dec 2020
-$18.31 M(-80.7%)
$37.92 M(-258.0%)
-$18.31 M(-75.7%)
Sep 2020
-
-$24.00 M(+8.5%)
-$75.28 M(-8.2%)
Jun 2020
-
-$22.12 M(+118.7%)
-$81.99 M(-1.8%)
Mar 2020
-
-$10.11 M(-46.9%)
-$83.49 M(-12.2%)
Dec 2019
-$95.04 M
-$19.05 M(-38.0%)
-$95.04 M(+2.5%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$30.71 M(+30.0%)
-$92.70 M(+19.7%)
Jun 2019
-
-$23.62 M(+9.0%)
-$77.46 M(+15.7%)
Mar 2019
-
-$21.66 M(+29.6%)
-$66.96 M(+11.8%)
Dec 2018
-$59.88 M(+113.0%)
-$16.71 M(+8.1%)
-$59.88 M(+20.9%)
Sep 2018
-
-$15.47 M(+17.9%)
-$49.52 M(+16.1%)
Jun 2018
-
-$13.12 M(-10.0%)
-$42.65 M(+34.4%)
Mar 2018
-
-$14.58 M(+129.3%)
-$31.73 M(+12.9%)
Dec 2017
-$28.11 M(+687.9%)
-$6.36 M(-26.0%)
-$28.11 M(+7.4%)
Sep 2017
-
-$8.59 M(+291.6%)
-$26.16 M(+41.3%)
Jun 2017
-
-$2.19 M(-80.0%)
-$18.51 M(+34.0%)
Mar 2017
-
-$10.97 M(+148.8%)
-$13.82 M(+287.3%)
Dec 2016
-$3.57 M(-21.3%)
-$4.41 M(+368.5%)
-$3.57 M(+48.2%)
Sep 2016
-
-$941.00 K(-137.7%)
-$2.41 M(-10.7%)
Jun 2016
-
$2.50 M(-448.9%)
-$2.69 M(-46.8%)
Mar 2016
-
-$716.00 K(-78.0%)
-$5.06 M(+11.7%)
Dec 2015
-$4.53 M(-188.5%)
-$3.25 M(+164.5%)
-$4.53 M(+550.2%)
Sep 2015
-
-$1.23 M(-1030.3%)
-$697.00 K(-117.1%)
Jun 2015
-
$132.00 K(-170.2%)
$4.07 M(+3.4%)
Mar 2015
-
-$188.00 K(-132.0%)
$3.94 M(-4.6%)
Dec 2014
$5.12 M(-225.5%)
$587.00 K(-83.4%)
$4.12 M(+16.6%)
Sep 2014
-
$3.54 M
$3.54 M
Dec 2013
-$4.08 M
-
-

FAQ

  • What is AnaptysBio annual EBITDA?
  • What is the all time high annual EBITDA for AnaptysBio?
  • What is AnaptysBio annual EBITDA year-on-year change?
  • What is AnaptysBio quarterly EBITDA?
  • What is the all time high quarterly EBITDA for AnaptysBio?
  • What is AnaptysBio quarterly EBITDA year-on-year change?
  • What is AnaptysBio TTM EBITDA?
  • What is the all time high TTM EBITDA for AnaptysBio?
  • What is AnaptysBio TTM EBITDA year-on-year change?

What is AnaptysBio annual EBITDA?

The current annual EBITDA of ANAB is -$92.74 M

What is the all time high annual EBITDA for AnaptysBio?

AnaptysBio all-time high annual EBITDA is $5.12 M

What is AnaptysBio annual EBITDA year-on-year change?

Over the past year, ANAB annual EBITDA has changed by +$50.42 M (+35.22%)

What is AnaptysBio quarterly EBITDA?

The current quarterly EBITDA of ANAB is -$3.79 M

What is the all time high quarterly EBITDA for AnaptysBio?

AnaptysBio all-time high quarterly EBITDA is $37.92 M

What is AnaptysBio quarterly EBITDA year-on-year change?

Over the past year, ANAB quarterly EBITDA has changed by +$13.06 M (+77.53%)

What is AnaptysBio TTM EBITDA?

The current TTM EBITDA of ANAB is -$92.74 M

What is the all time high TTM EBITDA for AnaptysBio?

AnaptysBio all-time high TTM EBITDA is $14.36 M

What is AnaptysBio TTM EBITDA year-on-year change?

Over the past year, ANAB TTM EBITDA has changed by +$32.87 M (+26.17%)